Health topic

Liver Safety

These are reviewed research connections, not a ranked list of remedies. An ingredient can appear here because evidence was uncertain, preclinical, or limited to a specific preparation and setting.

Ailment-to-evidence view

What the reviewed research points to

This order reflects the depth of the reviewed evidence, not which option works best or what anyone should take. Mixed and negative findings stay in the list because they can be more useful than a promising headline.

Deeper reviewed evidence Safety and tolerability only

Butterbur

The source establishes a chemically important preparation boundary: direct plant use can carry toxic alkaloid exposure, while controlled extraction requires deliberate raw-material selection and analytical verification.

Studied form
Raw butterbur plant material and the analytical processing needed to produce pyrrolizidine-alkaloid-controlled extracts
Outcome
Toxic pyrrolizidine alkaloids, plant-part selection, analytical testing, and alkaloid-free extract production
Evidence
Analytical and physiological narrative review
See the evidence and cautions →
How this order is calculated

Evidence syntheses come before individual randomized trials, which come before early human and preclinical work. Sample-size bands add a small amount. Positive, mixed, negative, and safety-only directions do not change the depth score. Study independence is not yet scored, so overlapping reviews must not be counted as separate confirmation.

Connected ingredients

What appears in the current evidence map

Source-linked records

1 reviewed record

Evidence synthesis Safety and tolerability only Plant chemistry and processing review, not a clinical trial

Butterbur's preparation boundary: the raw plant can contain toxic alkaloids

Butterbur is a good example of why a plant name is not enough. The raw plant can contain toxic pyrrolizidine alkaloids, so a clinical result for a processed extract cannot be transferred to tea, raw root, leaf material, or an unverified supplement. This review describes the chemistry and processing boundary; it is not a clinical safety trial and does not certify a retail product.

What was studied
Raw butterbur plant material and the analytical processing needed to produce pyrrolizidine-alkaloid-controlled extracts
Setting
Not an efficacy study
Why it ranks here
The source establishes a chemically important preparation boundary: direct plant use can carry toxic alkaloid exposure, while controlled extraction requires deliberate raw-material selection and analytical verification.
Limits and cautions
  • This is an analytical and physiological review, not a comparative clinical safety trial.
  • It does not estimate how often human liver injury occurs.
  • It does not certify any current retail product as PA-free.
  • A label claim is not the same as independent testing and quality control.
  • The review establishes a preparation boundary, not a dose recommendation.

Do not use raw or unverified butterbur. Products represented as PA-free still require trustworthy quality verification, and butterbur should not be used in pregnancy, breastfeeding, or for children without qualified medical guidance.